Nicol M, Deniau B, Rahli R, Genest M, Polidano E, Assad N
Sci Rep. 2025; 15(1):8104.
PMID: 40057546
PMC: 11890863.
DOI: 10.1038/s41598-025-91824-0.
Xiang J, An Y, Sun J, Xu J, Xiong Y, Wang S
Discov Oncol. 2025; 16(1):279.
PMID: 40055297
PMC: 11889302.
DOI: 10.1007/s12672-025-02021-4.
Mikhael S, Daoud G
Cancer Med. 2025; 14(4):e70681.
PMID: 39969135
PMC: 11837049.
DOI: 10.1002/cam4.70681.
Hatia R, Hwang L, Li R, Troisi C, Jalal P, Amos C
J Hepatocell Carcinoma. 2025; 12:93-106.
PMID: 39867264
PMC: 11762437.
DOI: 10.2147/JHC.S477141.
Szymczak-Pajor I, Drzewoski J, Kozlowska M, Krekora J, Sliwinska A
Pharmaceuticals (Basel). 2025; 18(1).
PMID: 39861118
PMC: 11768994.
DOI: 10.3390/ph18010055.
Clinical significance of lipid pathway-targeted therapy in breast cancer.
Li D, Jin P, Cai Y, Wu S, Guo X, Zhang Z
Front Pharmacol. 2025; 15():1514811.
PMID: 39834807
PMC: 11743736.
DOI: 10.3389/fphar.2024.1514811.
Unlocking the Heterogeneity in Acute Leukaemia: Dissection of Clonal Architecture and Metabolic Properties for Clinical Interventions.
Capelletti M, Montini O, Ruini E, Tettamanti S, Savino A, Sarno J
Int J Mol Sci. 2025; 26(1.
PMID: 39795903
PMC: 11719665.
DOI: 10.3390/ijms26010045.
Metformin and the risk of malignant tumors of digestive system: a mendelian randomization study.
Liu P, Xiao J, Xiao J, Zhou J
Diabetol Metab Syndr. 2025; 17(1):6.
PMID: 39773528
PMC: 11705776.
DOI: 10.1186/s13098-024-01573-9.
Diverse Applications of the Anti-Diabetic Drug Metformin in Treating Human Disease.
Roberts C, Raabe N, Wiegand L, Kadar Shahib A, Rastegar M
Pharmaceuticals (Basel). 2025; 17(12.
PMID: 39770443
PMC: 11677501.
DOI: 10.3390/ph17121601.
Clinical Effect of Treatment with Metformin for Type 2 Diabetes on Non-Small Cell Lung Cancer Patients Undergoing Immunotherapy: A Retrospective Study.
Wang Y, Sun Y, Hu J, Ma H
Int J Gen Med. 2025; 17:6595-6604.
PMID: 39759894
PMC: 11699848.
DOI: 10.2147/IJGM.S495449.
NF-kappa B signaling pathway is associated with metformin resistance in type 2 diabetes patients.
Mansouri V, Bandarian F, Razi F, Razzaghi Z, Rezaei-Tavirani M, Rezaei M
J Diabetes Metab Disord. 2024; 23(2):2021-2030.
PMID: 39610517
PMC: 11599502.
DOI: 10.1007/s40200-024-01458-8.
Type II diabetes and metformin use does not affect colorectal cancer prognosis.
Shahrivar M, Dietrich C, Glimelius B, Saraste D, Martling A, Buchli C
Int J Cancer. 2024; 156(9):1736-1745.
PMID: 39600254
PMC: 11887022.
DOI: 10.1002/ijc.35266.
The skeleton: an overlooked regulator of systemic glucose metabolism in cancer?.
Ronghe R, Tavares A
Front Oncol. 2024; 14:1481241.
PMID: 39588310
PMC: 11586348.
DOI: 10.3389/fonc.2024.1481241.
Metformin may improve the outcome of patients with colorectal cancer and type 2 diabetes mellitus partly through effects on neutrophil extracellular traps.
Saito A, Koinuma K, Kawashima R, Miyato H, Ohzawa H, Horie H
BJC Rep. 2024; 1(1):20.
PMID: 39516686
PMC: 11524073.
DOI: 10.1038/s44276-023-00022-w.
Metformin: Diverse molecular mechanisms, gastrointestinal effects and overcoming intolerance in type 2 Diabetes Mellitus: A review.
Mohamed S
Medicine (Baltimore). 2024; 103(43):e40221.
PMID: 39470509
PMC: 11521032.
DOI: 10.1097/MD.0000000000040221.
Aged Gut Microbiome Induces Metabolic Impairment and Hallmarks of Vascular and Intestinal Aging in Young Mice.
Cheng C, Ye L, Zuo Y, Wang Y, Wang L, Li F
Antioxidants (Basel). 2024; 13(10).
PMID: 39456503
PMC: 11505429.
DOI: 10.3390/antiox13101250.
The Research Progress of Metformin Regulation of Metabolic Reprogramming in Malignant Tumors.
Sui Q, Yang H, Hu Z, Jin X, Chen Z, Jiang W
Pharm Res. 2024; 41(11):2143-2159.
PMID: 39455505
DOI: 10.1007/s11095-024-03783-2.
The Interlinking Metabolic Association between Type 2 Diabetes Mellitus and Cancer: Molecular Mechanisms and Therapeutic Insights.
Asiri A, Al Qarni A, Bakillah A
Diagnostics (Basel). 2024; 14(19).
PMID: 39410536
PMC: 11475808.
DOI: 10.3390/diagnostics14192132.
Non-coding RNAs as potential targets in metformin therapy for cancer.
Zhang Y, Wu Y, Liu Z, Yang K, Lin H, Xiong K
Cancer Cell Int. 2024; 24(1):333.
PMID: 39354464
PMC: 11445969.
DOI: 10.1186/s12935-024-03516-w.
Unraveling the Mystery of Energy-Sensing Enzymes and Signaling Pathways in Tumorigenesis and Their Potential as Therapeutic Targets for Cancer.
Mirza Z, Karim S
Cells. 2024; 13(17.
PMID: 39273044
PMC: 11394487.
DOI: 10.3390/cells13171474.
